🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This trial is the cohort C part of a multicenter, open label Phase Ib/II cl...
Status
Recruiting
Location
Peking Union Medical College Hospital
Start Date
2025-04-11
Trial ID
NCT06821503
This study aims to observe and explore the efficacy and safety of Penpulima...
Status
Recruiting
Location
Shanghai Ninth People's Hostipal, Shanghai Jiao Tong University School of Medicine
Start Date
2023-10-30
Trial ID
NCT06081673
Treatments Being Tested
This study is a one-arm exploratory clinical study of Disitamab Vedotin for...
Status
Unknown
Location
Multiple Locations
Start Date
2022-09-01
Trial ID
NCT05488353
Treatments Being Tested
TQB2223 is a recombinant, fully humanized antibody that binds lymphocyte ac...
Status
Unknown
Location
Fujian Cancer Hospital
Start Date
2023-06-06
Trial ID
NCT05894421
Treatments Being Tested
This project is a clinical trial on the efficacy and safety of TQB2916 inje...
Status
Not Yet Recruiting
Location
Cancer Hospital Chinese Academy of Medical Science
Start Date
2024-07
Trial ID
NCT06500091
This is a prospective, open-label single-arm, exploratory, two-stage design...
Status
Unknown
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Start Date
2021-09
Trial ID
NCT05033587
Treatments Being Tested
We conducted a single-center, prospective randomized ,Parallel controls, op...
Status
Completed
Location
Qin li
Start Date
2019-05-01
Trial ID
NCT05809336
Treatments Being Tested
To evaluate the efficacy and safety of TQB2618 injection combined with Penp...
Status
Unknown
Location
Gansu Prouincial Cancer Hospital
Start Date
2023-05-23
Trial ID
NCT05783921
This study will evaluate the safety and efficiency of TQB2928 injection com...
Status
Terminated
Location
The Second People's Hospital of Hefei
Start Date
2024-05-24
Trial ID
NCT06297642
Treatments Being Tested
To explore the efficacy and safety of Penpulimab combined with SOX in the p...
Status
Unknown
Location
Multiple Locations
Start Date
2022-08-31
Trial ID
NCT05519202
Treatments Being Tested